首页> 美国卫生研究院文献>The EMBO Journal >Human serum amyloid P is a multispecific adhesive protein whose ligands include 6-phosphorylated mannose and the 3-sulphated saccharides galactose N-acetylgalactosamine and glucuronic acid.
【2h】

Human serum amyloid P is a multispecific adhesive protein whose ligands include 6-phosphorylated mannose and the 3-sulphated saccharides galactose N-acetylgalactosamine and glucuronic acid.

机译:人血清淀粉样蛋白P是一种多特异性粘附蛋白其配体包括6-磷酸化的甘露糖和3-硫酸化的半乳糖N-乙酰半乳糖胺和葡萄糖醛酸。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Carbohydrate recognition by amyloid P component from human serum has been investigated by binding experiments using several glycosaminoglycans, polysaccharides and a series of structurally defined neoglycolipids and natural glycolipids. Two novel classes of carbohydrate ligands have been identified. The first is 6-phosphorylated mannose as found on lysosomal hydrolases, and the second is the 3-sulphated saccharides galactose, N-acetyl-galactosamine and glucuronic acid as found on sulphatide and other acidic glycolipids that occur in neural or kidney tissues or on subpopulations of lymphocytes. Binding to mannose-6-phosphate containing molecules and inhibition of binding by free mannose-6-phosphate and fructose-1-phosphate are features shared with mannose-6-phosphate receptors involved in trafficking of lysosomal enzymes. However, only amyloid P binding is inhibited by galactose-6-phosphate, mannose-1-phosphate and glucose-6-phosphate. These findings strengthen the possibility that amyloid P protein has a central role in amyloidogenic processes: first in formation of focal concentrations of lysosomal enzymes including proteases that generate fibril-forming peptides from amyloidogenic proteins, and second in formation of multicomponent complexes that include sulphoglycolipids as well as glycosaminoglycans. The evidence that binding to all of the acidic ligands involves the same polypeptide domain on amyloid P protein, and inhibition data using diffusible, phosphorylated monosaccharides, is potentially important leads to novel drug designs aimed at preventing or even reversing amyloid deposition processes without interference with essential lysosomal trafficking pathways.
机译:通过使用几种糖胺聚糖,多糖以及一系列结构定义的新糖脂和天然糖脂的结合实验,研究了人类血清中淀粉样蛋白P成分对碳水化合物的识别。已经鉴定出两类新颖的碳水化合物配体。第一个是在溶酶体水解酶中发现的6-磷酸化甘露糖,第二个是在神经或肾脏组织或亚群中存在的硫酸盐和其他酸性糖脂上发现的3-硫酸化的半乳糖,N-乙酰基-半乳糖胺和葡萄糖醛酸。淋巴细胞。与包含溶酶体酶的运输的甘露糖-6-磷酸酯受体共有的特征是与含甘露糖6-磷酸的分子结合以及对游离甘露糖6-磷酸和果糖-1-磷酸的结合的抑制。然而,只有淀粉样蛋白P结合被6-磷酸半乳糖,1-磷酸甘露糖和6-磷酸葡萄糖抑制。这些发现加强了淀粉样蛋白P蛋白在淀粉样蛋白生成过程中发挥核心作用的可能性:首先是形成溶酶体酶的集中浓度,包括从淀粉样蛋白生成蛋白生成原纤维形成肽的蛋白酶,其次是形成包括硫糖脂的多组分复合物。作为糖胺聚糖。与所有酸性配体结合涉及淀粉样蛋白P蛋白上相同多肽结构域的证据,以及使用可扩散的磷酸化单糖的抑制数据的潜在重要证据,导致了旨在防止甚至逆转淀粉样蛋白沉积过程而又不干扰必需品的新型药物设计。溶酶体运输途径。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号